compound 15b [PMID: 16539403]   Click here for help

GtoPdb Ligand ID: 8194

Compound class: Synthetic organic
Comment: Compound 15b was desigend and assessed in a medicinal chemistry study to identify selective inhibitors of transforming growth factor-beta type I receptor kinase (TGFβR1) [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 68.76
Molecular weight 359.17
XLogP 2.61
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCCCn1cnc2c1cc(cc2)c1c2CCCn2nc1c1ccccn1
Isomeric SMILES OCCCn1cnc2c1cc(cc2)c1c2CCCn2nc1c1ccccn1
InChI InChI=1S/C21H21N5O/c27-12-4-10-25-14-23-16-8-7-15(13-19(16)25)20-18-6-3-11-26(18)24-21(20)17-5-1-2-9-22-17/h1-2,5,7-9,13-14,27H,3-4,6,10-12H2
InChI Key SYCWRTUPLPDKDX-UHFFFAOYSA-N
References
1. Li HY, Wang Y, Heap CR, King CH, Mundla SR, Voss M, Clawson DK, Yan L, Campbell RM, Anderson BD et al.. (2006)
Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7.
J Med Chem, 49 (6): 2138-42. [PMID:16539403]